Quarterly Report • May 12, 2023
Quarterly Report
Open in ViewerOpens in native device viewer


Puteaux, 12 May 2023 (8:15 am CEST)
ORPEA Group announces its consolidated results1 for the 2022 financial year ended 31 December 2022, approved yesterday by the Board of Directors, as well as its revenues for the 1 er quarter 2023.
1 The audit procedures on the consolidated financial statements have been performed by the Statutory Auditors. The certification report will be issued after verification of the management report and finalization of the procedures required for the filing of the Universal Registration Document. It will include an observation referring to the justification in the accounts of management's maintenance of the going concern accounting principle, as well as an observation on the change in IAS 16 method related to the abandonment of the revaluation method for real estate complexes.


Laurent Guillot, Chief Executive Officer, comments: "The 2022 financial statements reflect the profound reorganization and the scale of the change that had to be driven within the company. 2022 will have been a year of change for ORPEA. Today, we are looking to the future. The Refoundation of the Group is well underway. In a few months, we have reconstituted an ethical and committed management team. We have redefined a strategy to serve our collaborators, care and support for patients, residents and their families. We have begun to restore our financial equilibrium to ensure the Group's long-term viability. Getting through these difficulties would never have been possible without the professionalism and commitment of our 76,000 employees who, on a daily basis, have never stopped caring for our residents and patients. I would like to sincerely thank them. Thanks to the proposed financial restructuring plan, which is to be submitted in the coming weeks to the vote of the classes of affected parties under the accelerated safeguard procedure, the Group will have a sound financial structure, the means to finance its Refoundation Plan, and will be able to devote itself serenely to the pursuit of its transformation."
As previously announced, while business remained resilient with growth of +8.9% for the year as a whole (including +5.5% organic), operating profitability was strongly affected, as the slight increase in the average occupancy rate was not sufficient to offset the effects of inflation and the decrease in Covid-19-related compensations. The 2022 EBITDAR margin fell sharply to 16.7% vs. 24.9% in 2021.
The 2022 consolidated financial statements include a significant decline in the value of assets recorded in the balance sheet. This is the result of asset impairments affecting the income statement in the amount of -€3.8 billion and a change in accounting method applied to real estate assets accounted for under IAS 16 in the amount of -€1.9 billion (excluding taxes), which is directly deducted from equity. This change of method was implemented in order to make ORPEA's accounts more comparable with those of companies with the same activity and consisted in restating the real estate assets at historical cost and no longer at revalued value (optional method under IAS 16). This total write-down of € -5.7 billion is in line with the forecast communicated on 21 December 2022. The impairments recorded are mainly the result of value tests carried out on the basis of the business plans specific to each establishment, drawn up as part of the strategic review carried out in the second half of the year.
On this basis, the Group's share of net result for the year 2022 is -€4 billion, leading to shareholders' equity of -€1.5 billion at the end of the year.
At 31 December 2022, the real estate portfolio was valued at €6.5 billion (including IFRS 5 assets held for sale), for a balance sheet value of €4.9 billion after the change in accounting method applied to the real estate assets previously accounted for using the optional IAS 16 method. As a reminder, as of 31 December 2021, the real estate portfolio was valued at €8.4 billion (including IFRS 5 assets held for sale), which corresponded to the revalued balance sheet value of the real estate complexes.
With regard to the progress of the financial restructuring, the Company has been benefitting from accelerated safeguard proceedings since 24 March 2023, in order to implement the accelerated safeguard plan proposed by the Company. This proposed plan has so far received majority support (approximately 51%) from ORPEA SA's unsecured financial creditors and the support of the Group's main banking partners. It will be submitted around mid-June to the vote of the classes of affected parties, including the existing shareholders of the Company.

The Group recalls that in the context of its financial restructuring, the envisaged capital increases will result in massive dilution for existing shareholders, who would hold, in the absence of reinvestment, less than 0.5% of the Company's share capital in the event of an accelerated safeguard plan approved by a two-thirds majority of all classes of affected parties, and less than 0.05% in the event of an accelerated safeguard plan imposed by cross-class cram down, which would be implemented in case of a negative vote by any of the classes.

On 24 March 2023, ORPEA SA entered into an accelerated safeguard procedure with a draft safeguard plan based in particular on the lock-up agreement signed on 14 February 2023 with the Groupement, which meets the objectives of ORPEA S.A. to achieve a sustainable financial structure and to finance its Refoundation Plan presented on 15 November 2022, and which is the subject of a majority support (approximately 51%) of its non-secured financial creditors, and on the agreement of 17 March 2023 concluded with the Group's main banking partners (the "G6") providing in particular for the implementation of additional financing of €400 million coupled with additional bridge financing of €200 million up to the second capital increase.
Taking into account:
The Company considers that, as of the date of closing of the accounts, it can have an estimated cash position compatible with its forecasted commitments and thus be in a position to meet its cash requirements over the next 12 months.
On this basis, the Board of Directors has approved the financial statements for the financial year ended 31 December 2022 in accordance with the going concern principle.

| M€ | 2 021 | 2 022 | Var. |
|---|---|---|---|
| Revenue | 4 299 | 4 681 | +8,9% |
| EBITDAR (*) | 1 070 | 780 | -27,1% |
| EBITDAR margin | 24,9% | 16,7% | -824bp |
| EBITDA | 1 041 | 756 | -27,4% |
| EBITDA margin (**) | 24,2% | 16,2% | -806bp |
| Current operating income | 396 | (49) | n.a |
| Current operating marqin | 9,2% | -1,0% | -1 026bp |
| Non-recurring items | (41) | (4 223) | n.a |
| Cost of net financial debt | (249) | (319) | +28,0% |
| Profit before tax | 106 | (4 591) | n.a |
| Group net profit | રિક | (4 027) | n.a |
(*) EBITDAR is used by the Group to analyse its operating performance. It corresponds to operating income before rental expenses not eligible for IFRS 16 "Leases", depreciation and provisions, other operating income and expenses, interest and taxes.
(**) L'EBITDA correspond à l'EBITDAR, après déduction des charges locatives en application de la norme IFRS 16
The amount of rents not deducted from EBITDA under IFRS 16 amounted to €359 million in financial year 2021 and €414 million in financial year 2022 (the increase being mainly due to the Group's development). EBITDA excluding the impact of IFRS 16 amounted to €682 million for the full year 2021 and €342 million for the full year 2022.
Revenue for 2022 amounted to €4,681 million, an increase of +8.9%, of which +5.5% was organic, in line with the target announced on 15 November 2022.
Revenue in France rose by +2.1% (of which +1.9% organic) despite the crisis affecting the Group's retirement homes. The other geographic regions recorded high growth rates thanks to the improvement in business linked to the gradual recovery from the health crisis and the ramp-up of newly opened facilities.
EBITDAR will be €780 million in 2022, representing a margin of 16.7%, compared with 24.9% in 2021. This decrease of a total of -824 bps, is mainly due to:
EBITDA amounted to €756 million compared with €1,041 million in 2021, representing a margin of 16.2% of revenues.

EBITDA excluding IFRS 16 amounted to €342 million, representing a margin of 7.3%.
Current operating income amounts to €-49 million, compared with €396 million in 2021. This evolution was mainly due to a decline in operating profitability and an increase in depreciation and amortization related to the opening of new facilities.
Income before tax was €4,591 million, including €4,223 million of non-recurring items resulting mainly from:
Net financial income was -€319 million, representing an increase of the expense of 28%. This change reflects the increase in gross financial debt, combined with higher interest rates and margins associated with the June 2022 refinancing.
Group net result for the financial year 2022 amounted to -€4,027 million.
| ME | 2021 Published 2021 Restated* | 2022 | |
|---|---|---|---|
| Net tangible assets | 8 069 | 6 157 | 5 001 |
| Net intangible assets | 3 076 | 3 076 | 1592 |
| Goodwill | 1 ਦਿੱਚੇ | 1 669 | 1 362 |
| Equity of the consolidated group | 3 811 | 2 335 | (1 502) |
| Gross financial debt (excluding IFRS 16 and IFR | 8 862 | 8 862 | ਰੇ 615 |
| Short-term debt | 1 856 | 1 856 | 8 236 |
| Cash flow | 952 | 952 | 856 |
| Net debt (excluding IFRS 16 and IFRS 5) | 7 910 | 7 910 | 8 758 |
| Lease commitments (IFRS 16) | 3 265 | 3 265 | 3 768 |

As of 31 December 2022, the book value of net tangible assets amounted to €5.0bn, down €3.1bn. This change is mainly due to impairment losses recognized on real estate assets (€1.4 billion recognized in the income statement) and a change in accounting method applied to real estate assets recognized under IAS 16 (€1.9 billion excluding the tax effect, recognized directly against equity).
At December 31, 2022, the balance sheet value of the real estate assets was €4.9 billion, with a total economic value of €6.5 billion. This amount includes €4.9 billion of assets valued by independent experts (based on an asset yield of 5.1%), the balance being maintained at book value.
Intangible assets and goodwill amounted to €1.6bn and €1.4bn respectively. These decreases, of €1.5 billion and €0.3 billion respectively, are mainly the result of impairment tests carried out on assets in accordance with IAS 36.
Cash and cash equivalents at the end of 2022 amounted to €856 million and €354 million at May 4, 2023.
Net financial debt amounted to €8.8bn (excluding IFRS 16 lease debt), up €0.8bn over the period. Given the covenants in the financing documentations of the Group, and notwithstanding the neutralization of their possible future consequences by the conciliation and accelerated safeguard procedures and their adjustment, an amount of €6.5bn of long-term financial debt directly and indirectly concerned has been reclassified in the accounts as financial liabilities due within one year. For the concerned debts at the level of ORPEA SA, the conciliation and accelerated safeguard procedures have led to a suspension of the contractual provisions relating to these covenants. As regards the other debts concerned, which are at the level of Group subsidiaries, the Company has obtained a waiver from the corresponding creditors since 31 December 2022, concerning their non-application at 31 December 2022 and a modification of these covenants. A sole indebtedness covenant (net debt/EBITDA excluding IFRS 16 < 9.0x) will be applicable as from June 2025.
The increase in gross financial debt of €0.8 billion (excluding IFRS 16 lease debt) is mainly related to tranches A and B put in place in June 2022, net of repayments of existing debt. More specifically, the corresponding cash contribution of €1.7 billion was used mainly to finance development capex (for nearly €0.55 billion), to service debt excluding G6 banks (interest and principal, for nearly €0.85 billion) and to service debt of G6 banks (interest and principal, for nearly €0.3 billion).
The maturity schedule of gross financial debt by type (excluding IFRS 16 rental debt and excluding accounting reclassifications to short-term debt) at the end of 2022 is summarized below:
| €m, YE 2022) | 2023 | 2024 | 2025 | 2026 | 2027 | > 2028 | Cum. |
|---|---|---|---|---|---|---|---|
| June 22 secured financing | 900 | 200 | 627 | 1 500 | 0 | 0 | 3 227 |
| Other secured debt (subs. and ORPEA SA) | 311 | 237 | 205 | 205 | 141 | 1 032 | 2 132 |
| Unsecured debt (subs. and ORPEA SA) | 593 | 625 | 785 | 607 | 734 | 1 013 | 4 357 |
| Total | 1 804 | 1 062 | 1 618 | 2 311 | 876 | 2 046 | 9 716 |

On a pro forma basis of the proposed financial restructuring (conversion in equity of €3.8 billion of unsecured debt of ORPEA S.A. and additional financing of €400 million), the maturity schedule of gross financial debt as of 31 December 2022 would be as follows:
| (€m, pro-forma of the financial restructuring) | 2023 | 2024 | 2025 | 2026 | 2027 | > 2028 | Cum. |
|---|---|---|---|---|---|---|---|
| June 22 secured financing | 200 | 200 | 300 | 200 | 2 327 | 0 | 3 227 |
| New Money G6 | 0 | 0 | 0 | 400 | 0 | 0 | 400 |
| Other secured debt (subs. and ORPEA SA) | 311 | 237 | 205 | 205 | 141 | 1 032 | 2 132 |
| Unsecured debt (subsidiaries) | 136 | 152 | 40 | 130 | 12 | 64 | 534 |
| Total | 647 | 589 | 546 | 935 | 2 481 | 1 096 | 6 294 |
Consolidated shareholders' equity stood at -€1.5bn at December 31, 2022, mainly due to the net loss for the year (-€4bn) and the impact of the change in accounting method applied to real estate projects accounted for under IAS 16 (-€1.5bn after tax effect).
| (ME) | |
|---|---|
| EBITDA excluding IFRS 16 | 342 |
| Cash / non-cash EBITDA adjustments | 11 |
| Change in. WCR (excl. tax) | (23) |
| Operating Capex | (136) |
| Taxes (cash) | (72) |
| OPERATING CASH FLOWS | 122 |
| Development Capex | (638) |
| Real Estate Disposals | 132 |
| Non-current items | (152) |
| Net financial expenses | (215) |
| Net Financial Investments | (94) |
| Changes in scope | (31) |
| Others | (40) |
| VAR. NET FINANCIAL DEBT (exc. IFRS) | (916) |
| NET FINANCIAL DEBT (exc. IFRS) 12/31/20. | (1 944) |
| var net debt | (916) |
| NET FINANCIAL DEBT (exc. IFRS) 31/12/20. | (8 860) |
Cash flow from operating activities amounted to €122 million after deducting maintenance Capex and IT Capex.
Development capex, mainly real estate (Greenfield projects), amounted to €638 million, down from the forecast of 15 November 2022 (€705 million).
The real estate disposals result mainly from a transaction in the Netherlands.
Non-current items include expenses related to the management of the crisis experienced by the Group.
At the end of 2022, net financial debt (excluding IFRS) had increased by €916 million to €8,860 million.

The 2022-2025 Business Plan underlying the Refoundation Plan presented on 15 November 2022 has been updated to take into account, on the one hand, the 2022 achievements and the consequences of the various reviews carried out in the context of the closing of the 2022 accounts, and, on the other hand, the terms and conditions of the proposed accelerated safeguard plan (to be related to the assumptions related to the financial restructuring that had been retained last fall).
The business outlook for the 2022-2025 period remains broadly unchanged, the only notable differences being an accounting reclassification of IT expenditure from capital expenditure to operating expenditure (€19m in 2022, €30m for subsequent years), with no impact on operating flows (lower EBITDAR offset by lower capex), and a slight downward revision of the development capex envelope over the period (nearly €75m out of a total of around €1.6bn).
The financial projections are essentially impacted by the terms and conditions of the draft Safeguard Plan, namely a cash capital increase of €1.55 billion (compared to an average of €1.4 billion in the vision of 15 November 2022) and an additional secured financing of €0.4 billion (instead of €0.6 billion in the vision of 15 November 2022 and excluding bridge financing of €0.2 billion in 2023).
On this basis, and before taking into account the commitment made to the G6 banks regarding real estate disposals, the Group's net debt is now projected at €4.5bn at the end of 2025 (instead of €4.9bn), corresponding to a leverage of 6.3x (instead of 6.5x), based on a 2025 EBITDA excluding IFRS 16 of €715m (instead of €745m).
With a view to achieving the objective of reducing the Group's holding of real estate assets in operation to 20-25%, the Group has made a commitment to the G6 banks and in the context of the safeguard plan to dispose of at least €1.25 billion of real estate assets (in gross value and excluding rights) over the period 2022-2025. These additional real estate disposals will leave the Group's EBITDAR unchanged, but will lead to a reduction in EBITDA excluding IFRS 16 due to the addition of rental payments corresponding to the leases on the real estate assets sold, this new expense being partially offset by the reduction in financial expenses concomitant with the repayment of the Group's debt with the net proceeds from the real estate disposals.
In total, taking into account the net proceeds of additional real estate disposals and other impacts related to these disposals (higher rents in the face of lower financial charges), compared to the initial plan the updated Business Plan finally projects that the Group's net debt will be reduced to nearly €3.7 billion at the end of 2025, corresponding to a leverage of 5.5x (instead of 6.3x), based on a 2025 EBITDA excluding IFRS 16 reduced to €671 million (instead of €715 million)
In accordance with the applicable legal provisions, the Company requested and obtained from the President of the Commercial Court of Nanterre an extension of the meeting time of the General Meeting of Shareholders responsible for approving the financial statements for the financial year which ended 31 December 2022. The order issued by the President of the Nanterre Commercial Court on 11 May, 2023 extends the meeting deadline to 29 December 2023. Consequently, the Company will convene and hold its annual shareholders' meeting before this date and, in any event, following acquisition of their stake in the capital of the Company by the new shareholders.

| M€ | CA Q1 2022 | CA Q1 2023 | Growth % | Organic growth % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % |
|---|---|---|---|---|
| FRANCE BENELUX UK IRELAND | 679,2 | 720,1 | +6,0% | +5,8% |
| CENTRAL EUROPE | 283,3 | 322,2 | +13,7% | +12,6% |
| EASTERN EUROPE | 101,1 | 121,1 | +19,7% | +19.6% |
| IBERIAN PENINSULA + LATAM | 55,5 | 69,2 | +24,7% | +21,8% |
| OTHER COUNTRIES | 1,0 | 1,8 | +88,0% | +3,4% |
| Total | 1 120,0 | 1234,4 | +10,2% | +9,5% |
Geographic breakdown: Central Europe (Germany, Italy and Switzerland), Eastern Europe (Austria, Poland, Czech Republic, Slovenia, Latvia, Croatia), Iberian Peninsula and Latin America (Spain, Portugal, Brazil, Uruguay, Mexico, Colombia, Chile), Other countries (China).
* The organic growth in Group revenues includes: 1. the change in revenues (N vs. N-1) of existing facilities resulting from changes in their occupancy rates and daily rates; 2. the change in revenues (N vs. N-1) of facilities restructured or whose capacity was increased in N or in N-1; 3. the revenues generated in N by facilities created in N or in N-1; 3. Revenues generated in N by facilities created in N or N-1, and the change in revenues of recently acquired facilities over a period equivalent in N to the consolidation period in N-1.
ORPEA recorded growth of +10.2% in the first quarter of 2023, of which +9.5% was organic.
In Q1 2023, the average occupancy rate was 83%, up +160bps vs. Q1 2022.
In France, business was solid in the clinics, while the occupancy rate in long-term care facilities has not yet recovered.
In Central and Eastern Europe and in the Iberian Peninsula and Latin America, business benefited from an increase in occupancy rates and a favorable price effect.
| Average occupancy rate | Q1 2022 | Q1 2023 Var. (bps) | |
|---|---|---|---|
| France Benelux UK Ireland | 84,9% | 83,8% | (115) bps |
| Central Europe | 78,1% | 81,5% | 340 bps |
| Eastern Europe | 80,9% | 83,7% | 287 bps |
| Iberian Peninsula + Latam | 74,4% | 83,2% | 886 bps |
| Other countries | 83,5% | 42,9% (4062) bps | |
| Total | 81,4% | 83,0% | 160 bps |
The Company has been under accelerated safeguard procedure ("procédure de sauvegarde accélérée") since 24 March 2023. The purpose of this procedure is to allow the implementation of the accelerated safeguard plan proposed by the Company. This draft plan has so far received the support of the majority (approximately 51%) of ORPEA SA's unsecured financial creditors and the

support of the Group's main banking partners. It is to be submitted around mid-June to a vote of the classes of parties affected, including the existing shareholders of the Company.
The envisaged plan provides for 3 capital increases:
In the event that the Accelerated Safeguard Plan is not approved by one or more of the classes of affected parties, it may, pursuant to article L.626-32 of the French Commercial Code, be approved by the Commercial Court at the request of the Company or the judicial administrator with the agreement of the Company and be imposed on the class or classes of affected parties that did not vote in favor of it, subject to compliance with the conditions set forth in the aforementioned provisions ("cross-class cram-down").
In such cross-class cram-down scenario, the Accelerated Safeguard Plan will provide for the issuance, in the context of each of the planned capital increases, of a number of new shares ten times higher than the number of new shares that would be issued in the hypothesis of a favorable vote of the Accelerated Safeguard Plan by each of the classes of affected parties, resulting in a dilution of the existing shareholders (in the event that they decide not to participate in any of the capital increases), ten times higher, in the event of cross-class cram-down. This would result, in the event of cross-class cram-down, in the issuance of new shares at issue prices ten times lower than the issue prices applicable in the event of a favorable vote of the Accelerated Safeguard Plan by each of the classes of affected parties.
The Group reminds that in the context of its financial restructuring, the envisaged capital increases will lead to a massive dilution for the existing shareholders, who would hold, upon completion of the financial restructuring, and if they decide not to participate in the capital increases, approximately 0.4% of the Company's share capital in the event of approval of the accelerated safeguard plan by each of the classes of affected parties, and approximately 0.04% in the event of non-approval of the accelerated safeguard plan by at least one of the classes of affected parties.
On the basis of the financial parameters on which the draft Safeguard Plan is based and in application of the aforementioned principles, assuming an approval of the accelerated Safeguard Plan by each of the classes of affected parties, the issue price of the first capital increase with preferential subscription rights (conversion into capital of the unsecured debt of ORPEA SA) would be approximately € 0.60 per share, the issue price of the second capital increase (capital increase allowing the entry of the Groupement) would be approximately € 0.18 per share and the issue price of the third capital increase with preferential subscription rights (capital increase in cash) would be approximately € 0.13 per share, i.e. at levels significantly below the current share price. Thus, under these conditions, the theoretical unit value, after the various transactions on the capital and before any possible consolidation of shares, would be less than €0.20 per share.

On the basis of the financial parameters on which the draft Safeguard Plan is based and in application of the aforementioned principles, in the event of non-approval of the accelerated Safeguard Plan by at least one of the classes of affected parties, the issue price of the first capital increase with preferential subscription rights (conversion into capital of the unsecured debt of ORPEA SA) would be approximately € 0.06 per share, the issue price of the second capital increase (capital increase reserved for the Groupement, with a priority subscription right for existing shareholders in the event that the shareholders, gathered in a class of affected parties, do not approve the plan) would be approximately €0.018 per share and the issue price of the third capital increase with preferential subscription rights (capital increase in cash) would be approximately €0.013 per share. This would lead to a theoretical unit value, after the various transactions and before any possible consolidation of shares, of less than €0.02 per share.
In both cases, the issue price of the new shares of the first capital increase is more than three times higher than the issue price of the shares of the second capital increase, as well as the theoretical unit value of the share after all operations.

ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 255,000 patients and residents each year.
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120, MSCI Small Cap Europe and CAC Mid 60 indices.
| Investor Relations | Investor Relations | Press Relations |
|---|---|---|
| ORPEA | NewCap | ORPEA |
| Benoit Lesieur | Dusan Oresansky | Isabelle Herrier-Naufle |
| Investor Relations Manager | Tel: 01 44 71 94 94 | Press Relations Director |
| [email protected] | [email protected] | Tel: 07 70 29 53 74 |
| [email protected] | ||
| Toll-free number for shareholders : | Image 7 | |
| 0 805 480 480 | ||
| Charlotte Le Barbier | ||
| Tel: 06 78 37 27 60 | ||
| [email protected] | ||
| Laurence Heilbronn |
This press release contains forward-looking statements that involve risks and uncertainties, including those included or incorporated by reference, regarding the Group's future growth and profitability that could cause actual results to differ materially from those indicated in the forward-looking statements. These risks and uncertainties relate to factors that the Company cannot control or accurately estimate, such as future market conditions. The forward-looking statements in this press release constitute expectations of future events and should be treated as such. Actual events or results may differ from those described in this document due to a number of risks or uncertainties described in the Company's 2021 Universal Registration Document, which is available on the Company's website and on the AMF website (www.amf-france.org), and in the 2022 Half-Year Financial Report, which is available on the Company's website.

| Organic growth | Organic growth in Group revenues includes : 1. The change in revenues (N vs. N-1) of existing facilities as a result of changes in their occupancy rates and per diem prices; 2. The change in sales (N vs. N-1) of establishments restructured or whose capacities were increased in N or N 1; 3. The sales achieved in N by establishments created in N or in N-1, and the change in sales of recently acquired establishments over a period equivalent in N to the consolidation period in N-1. |
|---|---|
| EBITDAR | EBITDAR is used by the Group to analyse its operating performance. It corresponds to operating income before rental expenses not eligible for IFRS 16 "Leases", depreciation and provisions, other operating income and |
| EBITDA | expenses, interest and taxes. EBITDA Corresponds to EBITDAR, after deduction of rental expenses in accordance with IFRS 16 |
| Net financial debt | Long-term financial debt + short-term financial debt - cash and marketable securities (excluding lease liabilities - IFRS 16 and IFRS 5 liabilities) |
| Capitalization rate | The capitalization rate of real estate or rate of return is the ratio between the rent and the value of the building |
| Cash-flow from operations | Cash flow from operating activities includes the cash impact of operations |

| Consolidated income statement in €m |
2021 | 2022 |
|---|---|---|
| REVENUE | 4 299 | 4 681 |
| Staff costs | (2 644) | (3 028) |
| Purchases used and other external expenses | (732) | (939) |
| Taxes and duties | (26) | (63) |
| Depreciation, amortisation and charges to provision | (645) | (805) |
| Other recurring operating income and expenses | 144 | 105 |
| Recurring operating profit | 396 | (49) |
| Other non-recurring operating income and expenses | (41) | (4 223) |
| OPERATING PROFIT | 355 | (4 272) |
| Net financial expense | (249) | (319) |
| PROFIT BEFORE TAX | 106 | (4 591) |
| Income tax expense | (38) | 596 |
| Share in profit (loss) of associates and JV | (1) | (33) |
| Profit (loss) attributable to non-controlling interest | (2) | 1 |
| NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS | 65 | (4 027) |

| Consolidated balance sheet - in €m | 31-Dec-21 | 31-déc-21 restated IAS 16) |
31/12/2022 |
|---|---|---|---|
| Non-current assets | 16 181 | 14 269 | 12 226 |
| Goodwill | 1 669 | 1 669 | 1 362 |
| Net intangible assets | 3 076 | 3 076 | 1 592 |
| Net tangible assets | 7 237 | 5 324 | 4 375 |
| Assets in progress | 832 | 832 | 627 |
| Right of use assets | 3 073 | 3 073 | 3 500 |
| Other non-current assets | 294 | 294 | 770 |
| Current assets | 2 415 | 2 415 | 1 915 |
| Cash and short-term investments | 952 | 952 | 856 |
| Assets held for sale | 388 | 388 | 353 |
| - | - | ||
| TOTAL ASSETS | 18 984 | 17 072 | 14 494 |
| - | - | ||
| Equity - Group share | 3 799 | 2 324 | (1 502) |
| Consolidated equity | 3 811 | 2 335 | (1 502) |
| Non-current financial liabilities | 11 632 | 11 195 | 5 979 |
| Long-term debt | 7 007 | 7 007 | 1 378 |
| Long-term lease commitments | 2 968 | 2 968 | 3 424 |
| Provisions for liabilities and charges | 223 | 148 | 296 |
| Deferred tax liabilities and other non-current liabilities | 1 434 | 75 | 66 |
| Current liabilities | 3 541 | 997 | 814 |
| Current financial liabilities | 3 541 | 3 541 | 9 962 |
| Short-term debt | 1 856 | 1 856 | 8 236 |
| Short-term lease commitments | 297 | 297 | 344 |
| Provisions | 22 | 22 | (0) |
| Trade payables | 335 | 335 | 327 |
| Tax and payroll liabilities | 329 | 329 | 412 |
| Current income tax liabilities | 69 | 69 | 112 |
| Other payables, accruals and prepayments | 633 | 633 | 529 |
| Liabilities for sale | - | - | 56 |
| TOTAL LIABILITIES | 18 984 | 17 072 | 14 494 |
| 31/12/2022 | 31/12/2021 | |
|---|---|---|
| M€ | ||
| Operating cash-flow | ||
| Consolidated Net Earnings | (4,027,579) | 66,861 |
| Elimination of charges and incomes with no impact on operating cash-flows | 3,907,079 | 285,056 |
| IFRS 16 impact | 350,498 | 294,300 |
| Financial income | 182,120 | 168,730 |
| Financial expense on rental commitment | 97,939 | 80,167 |
| Capital gains on disposals not related to operations (net of tax) | 0 | 0 |
| Consolidated companies' gross cash-flow | 510,057 | 895,114 |
| Change in working capital requirements related to operations | ||
| - Inventory |
181 | 4,089 |

| - Account receivable |
(7,109) | (198,406) |
|---|---|---|
| - Other receivable |
28,959 | (8,027) |
| - Tax and payroll tax expenses |
124,548 | 51,383 |
| - Account payable |
37,215 | 25,381 |
| - Other payable |
(284,124) | (15,783) |
| Net operating cash-flow | 409,728 | 753,751 |
| Investment and development cash-flow | ||
| Capital expenditure | (158,711) | (1,270,736) |
| Real estate sales | 132,490 | 284,125 |
| Other acquisitions and changes | (631,268) | (421,906) |
| Net investment cash-flow | (657,489) | (1,408,517) |
| Financing cash flow | ||
| Dividend paid to parent company sharholders | 0 | (58,168) |
| Net receipts – (disbursements) related to bridge loans and bank overdrafts | 0 | 53,558 |
| Receipts from new leasing agreements | 0 | 152,201 |
| Receipts from other loans | 3,398,461 | 2,265,693 |
| Repayments of lease liabilities | (415,891) | (294,300) |
| Repayments related to other loans | (2,470,057) | (991,880) |
| Repayments related to leasing agreements | (148,557) | (159,908) |
| Net financial income and other variations | (182,146) | (248,897) |
| Net financing cash-flow | 151,809 | 718,299 |
| Change in cash-flow | (95,952) | 63,533 |
| Opening cash-flow | 952,369 | 888,836 |
| Closing cash flow | 856,417 | 952,369 |
| Cash on the balance sheet | 856,417 | 952,369 |
| Cash flow equivalents | 258,991 | 11,586 |
| Cash flow | 597,426 | 940,782 |

| Income statement aggreagates IFRS 16 | FY 2021 | FY 2022 |
|---|---|---|
| EBITDA excl. IFRS16 | 682 | 342 |
| Rental IFRS 16 | 359 | 414 |
| EBITDA margin excl. IFRS 16 | 15,9% | 7,3% |
| Recurring operating profit excl. IFRS 16 | 337 | -112 |
| Recurring operating margin ex IFRS 16 | 7,8% | -2,4% |
| Cash Flow ex IFRS 16 | FY 2021 | FY 2022 |
| Operating cash flow [excl. IFRS 16] | +401 | (4) |
| Net Investment cash flows | (1 405) | (657) |
| Net financing flows [excl. IFRS 16] | +1 068 | +566 |
| Change in cash | +64 | (96) |
| Reminder of cash-flow "GAAPS" | FY 2021 | FY 2022 |
| Cash flow from operations (after tax) | +895 | +510 |
| change in working capital | (141) | (100) |
| Net cash generated from operating activities | +754 | +410 |
| Cash flow from investing and development | (1 409) | (657) |
Net cash from financing activities +718 +152 Change in cash +64 (96)

Update of the financial projections presented on 15 November 2022 in the light of the 2022 financial statements and the terms and conditions of the Accelerated Safeguard Plan (Plan de Sauvegarde Accélérée)
The business outlook for the 2022-2025 period covering the implementation of the Refoundation Plan and presented on 15 November 2022 remains unchanged at this stage, with the first years of the business plan corresponding to the 2022 achievements and the 2023 budget approved by the Company Board of Directors at the beginning of the year. Nevertheless, the financial projections attached to these forecasts, as well as certain management indicators and targets for 2025, must be updated in the light of, on the one hand, the 2022 achievements and the various reviews carried out in the context of the 2022 financial statements, and, on the other hand, the terms and conditions of the draft accelerated safeguard plan as set out in the lock-up agreement concluded with the Groupement and a majority of the non-secured creditors of ORPEA SA and the agreement concluded with the G6 banks on 17 March. These terms and conditions are to be reported to the financial restructuring assumptions adopted on 15 November 2022.
The detailed review carried out in the context of the 2022 financial statements led to the reclassification of certain IT expenses as operating expenses (OPEX) when they were classified as capital expenses (CAPEX) in the vision of 15 November 2022. This has the consequence of reducing, all other things being equal, EBITDAR and EBITDA excluding IFRS 16 by nearly € 19 million in 2022 and € 30 million on an annual basis in 2023 and following years (due to the ramp-up of the IT program). In return, CAPEX IT is reduced by the same amount, leading to this new accounting treatment being neutral in terms of operating cash flow.
The completion of the balance sheet review work, the analysis of the cut-off at the end of 2022, marked by significant differences in payments from one year to the next, and the continuation of the detailed review of the projects under development led to the updating of CAPEX forecasts and other operational flows (changes in WCR, non-current items, etc.) in the 2023-2025 period. In this context, from one vision (15 November 2022) to the next (May 2023) and cumulatively in the period 2022-2025:
On this basis, and taking better account of the effects of changes in the scope of consolidation, the net impact of the update would be a reduction in net debt at the end of 2025 of approximately € 50 million.

The main differences between the terms and conditions of the safeguard plan and the assumptions relating to the financial restructuring originally envisaged are as follows:
On these bases, the savings in the cumulative interest expense (approximately € 90 million), the larger capital increase in cash (€150 million) and the increase in the amount of equitized non-secured debt (approximately €60 million) would lead to a reduction in net debt at the end of 2025 of approximately €300 million.
Under these conditions, and before taking into account the commitment regarding real estate disposals made to G6 banks, the Group's net debt would amount to €4.5 billion at the end of 2025 (instead of €4.9 billion), corresponding to a leverage of 6.3x (instead of 6.5x), based on 2025 EBITDA excluding IFRS 16 of €715 million (instead of €745 million).
In view of the objective of a future holding of the operating real estate portfolio reduced to 20-25%, the Group has committed to G6 banks and, as part of the safeguard plan, to have made at least 1.25 billion euros in real estate disposals (gross value and excluding duties) over the 2022-2025 period. Compared to the current flow of real estate disposals that was included in the business plan presented on 15 November 2022, this corresponds to an additional volume of real estate disposals of nearly € 1.0 billion over the years 2024-2025.
These additional real estate disposals will leave the Group's EBITDAR unchanged but will lead to a reduction in EBITDA outside IFRS 16 by adding rents corresponding to leases of the transferred real estate assets, this new expense being partially offset by the reduction in financial expenses associated with the repayment of the Group's debt with net income from property disposals.
In total, based on net income (after tax) from additional real estate sales estimated at nearly €850 million and an accumulated balance of rent / savings in financial expenses amounting to nearly €20 million in aggregate, the Group's net debt would be reduced to € 3.7 billion at the end of 2025, corresponding to a leverage of 5.5x (instead of 6.3x), based on EBITDA 2025 excluding IFRS 16 reduced to €671 million (instead of €715 million).

In conclusion, the updated vision of the 2022-2025 Business Plan underpinning the Refoundation Plan, taking into account the terms and conditions of the proposed accelerated safeguarding plan, including the commitment to implement a €1.25 billion property sale program overthe 2022-2025 period, is based on an EBITDA sequence excluding IFRS 16 adjusted as follows:
| EBITDA (excl. IFRS 16) in € million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Vision 15 November 2022 | 358 | 433 | ਦਰਤ | 745 |
| Impact Execution 2022 | +3 | +0 | +0 | +0 |
| Reclassification of IT expenses to OPEX | -19 | -30 | -30 | -30 |
| Impact Real estate disposal program | +0 | +0 | -16 | -प्री |
| Vision May 2023 | 342 | 403 | 547 | 671 |
Furthermore, on the basis of this new EBITDA sequence excluding IFRS 16 and the new financial projections corresponding to the terms and conditions of the accelerated safeguard plan, the net debt and financial leverage projected at the end of 2025 would be adjusted as follows:
| Amounts in m€ Net debt excluding IFRS adjustments IFRS / EBITDA excl. IFRS 16 |
Net Debt End of 2025 |
EBITDA 2025 |
Lever ND / EBITDA |
|---|---|---|---|
| Vision 15 November 2022 | 4 873 | 745 | 6,5x |
| Updated vision before taking into account the commitment of real estate disposals |
4 522 | 715 | 6,3x |
| Vision May 2023 | 3 692 | 671 | 5,5x |



| Amounts in € millions | 2022 | 2023 | 2024 | 2025 | Cumulative 2022-2025 |
|---|---|---|---|---|---|
| Turnover | 4 688 | 5 326 | 5 737 | 6 102 | |
| EBITDAR | 797 | 911 | 1 083 | 1 246 | |
| EBITDAR margin | 17,0% | 17,1% | 18,9% | 20,4% | |
| EBITDA (excluding IFRS 16) | 358 | 433 | ਦਰਤ | 745 | 2 129 |
| EBITDA margin | 7,6% | 8,1% | 10,3% | 12,2% | |
| Maintenance and IT capex | -223 | -233 | -236 | -242 | -933 |
| Other current operating flows | -77 | -68 | -62 | -31 | -239 |
| Operating cash flow | ਟਰ | 132 | 295 | 471 | 958 |
| Development Capex | -705 | -544 | -216 | -132 | -1 597 |
| Cash flow after CAPEX | -646 | -411 | 79 | 339 | -639 |
| of which total CAPEX | -928 | -776 | -452 | -374 | -2 530 |
| Non-current items | -159 | -200 | -33 | -33 | -425 |
| Asset portfolio management | 1 | 51 | 23 | -24 | 52 |
| Debt Charge | -221 | -319 | -245 | -241 | -1 027 |
| Cash flow before financing | -1 026 | -879 | -176 | 42 | -2 039 |
| New Money | 2 000 | 2 000 | |||
| Removal / (repayment) of debts | 695 | -416 | -367 | -239 | -327 |
| Net cash flow | -331 | 705 | -543 | -197 | -366 |
| Cash and cash equivalents as of 31/12 | 622 | 1 327 | 783 | 586 | |
| Net financial debt (excluding IFRS adj.) | 9 026 | 4 739 | 4 915 | 4 873 | |
| Financial leverage (NFD/EBITDA) | 25,2x | 10.9x | 8.3x | 6.5x |

| Amounts in Em | 2022 | 2023 | 2024 | 2025 | Cumulated 2022-2025 |
|---|---|---|---|---|---|
| EBITDA (excluding IFRS 16) | -16 | -30 | -30 | -30 | -106 |
| IT and service capex | +87 | +18 | +30 | +30 | +165 |
| Other current operating cash flows | -8 | -76 | +45 | -19 | - ਦੇਖੋ |
| Operating cash flow | +62 | -88 | +45 | -19 | -0 |
| Development capex | +67 | +66 | -66 | 48 | +75 |
| Cash flow post CAPEX | +130 | -23 | -21 | -11 | +75 |
| Non-recurring items | +8 | +34 | -18 | -24 | +0 |
| Management of the asset portfolio | +38 | -76 | +38 | +0 | +0 |
| Cost of debt | +6 | +1 | +51 | +40 | +98 |
| Cash flow before financing | +181 | -63 | +50 | +5 | +172 |
| New Money | -450 | +400 | -50 | ||
| Raising / (reimbursement) of debt | +54 | -245 | -220 | +199 | -213 |
| Net cash flow | +235 | -759 | +230 | +203 | -91 |
| Amounts in Em | 2022 | 2023 | 2024 | 2025 | Cumulated 2022-2025 |
|---|---|---|---|---|---|
| Revenue | 4 681 | 5 326 | 5 737 | 6 102 | |
| EBITDAR | 780 | 881 | 1 053 | 1 216 | |
| EBITDAR margin | 16,7% | 16,5% | 18,4% | 19,9% | |
| EBITDA (excluding IFRS 16) | 342 | 403 | ਟਵਤ | 715 | 2 023 |
| EBITDA margin | 7,3% | 7,6% | 9,8% | 11,7% | |
| IT and service capex | -136 | -215 | -206 | -212 | -768 |
| Other current operating cash flows | -85 | -145 | -17 | -21 | -297 |
| Operating cash flow | 122 | 44 | 340 | 452 | 958 |
| Development capex | -638 | -478 | -282 | -124 | -1 522 |
| Cash flow post CAPEX | -516 | -434 | 58 | 328 | -564 |
| including total CAPEX | -774 | -693 | -488 | -336 | -2 290 |
| Non-recurring items | -151 | -165 | -51 | -57 | -425 |
| Management of the asset portfolio | ਤਰੇ | -25 | 61 | -24 | 52 |
| Cost of debt | -215 | -318 | -194 | -201 | -929 |
| Cash flow before financing | -844 | -942 | -126 | 46 | -1 867 |
| New Money | 1 550 | 400 | 1 950 | ||
| Raising / (reimbursement) of debt | 748 | -661 | -587 | -40 | -540 |
| Net cash flow | -96 | -54 | -313 | e | -457 |
| Cash flow as of 31/12 | જરૂર | 803 | 489 | 496 | |
| Net Financial Debt (excluding IFRS adj.) | 8 860 | 4 443 | 4 569 | 4 522 | |
| Finanl Leverage (Fnet in. Debt/ EBITDA) | 25,9x | 11,0x | 8,1x | 6,3x |

| lmpacts related to the implementation of the real estate sale program | ||||
|---|---|---|---|---|
| ----------------------------------------------------------------------- | -- | -- | -- | -- |
| Amounts in €m | 2022 | 2023 | 2024 | 2025 | Cumulated 2022-2025 |
|---|---|---|---|---|---|
| EBITDA (excluding IFRS 16) | +0 | -16 | -44 | -60 | |
| Other current operating cash flows | +0 | +0 | +7 | +7 | |
| Operating cash flow | +0 | -16 | -37 | -53 | |
| Management of the asset portfolio | +0 | +425 | +425 | +850 | |
| Cost of debt | +0 | +5 | +28 | +33 | |
| Cash flow before financing | +0 | +414 | +416 | +830 | |
| New Money | -400 | +400 | +0 | ||
| Raising / (reimbursement) of debt | +0 | -139 | -617 | -756 | |
| Net cash flow | +0 | -124 | +198 | +74 |
| Amounts in Em | 2022 | 2023 | 2024 | 2025 | Cumulated 2022-2025 |
|---|---|---|---|---|---|
| Revenue | 4 681 | 5 326 | 5 737 | 6 102 | |
| EBITDAR | 780 | 881 | 1 053 | 1 216 | |
| EBITDAR margin | 16,7% | 16,5% | 18,4% | 19,9% | |
| EBITDA (excluding IFRS 16) | 342 | 403 | 547 | 671 | 1 964 |
| EBITDA margin | 7,3% | 7,6% | 9,5% | 11,0% | |
| IT and service capex | -136 | -215 | -206 | -212 | -768 |
| Other current operating cash flows | -85 | -145 | -17 | -44 | -291 |
| Operating cash flow | 122 | 44 | 324 | 415 | 905 |
| Development capex | -638 | -478 | -282 | -124 | -1 522 |
| Cash flow post CAPEX | -516 | -434 | 42 | 291 | -617 |
| including total CAPEX | -774 | -693 | -488 | -336 | -2 290 |
| Non-recurring items | -151 | -165 | -51 | -57 | -425 |
| Management of the asset portfolio | ਤਰੇ | -25 | 486 | 401 | 902 |
| Cost of debt | -215 | -318 | -189 | -173 | -896 |
| Cash flow before financing | -844 | -942 | 288 | 462 | -1 037 |
| New Money | 1 550 | 0 | 400 | 1 950 | |
| Raising / (reimbursement) of debt | 748 | -661 | -726 | -657 | -1 296 |
| Net cash flow | -96 | -54 | -488 | 205 | -383 |
| Cash flow as of 31/12 | 856 | 803 | રૂદર | 570 | |
| Net Financial Debt (excluding IFRS adj.) | 8 860 | 4 443 | 4 154 | 3 692 | |
| Finanl Leverage (Fnet in. Debt/ EBITDA) | 25,9x | 11,0x | 7,6x | 5,5x |

APPENDIX 3: financial presentation dated 12 May 2023
12 May 2023



REFOUNDATION PLAN IN PROGRESS Laurent Guillot Chief Executive Officer 1
2022 FULL-YEAR RESULTS AND Q1-2023 REVENUES 2 UPDATE ON FINANCIAL RESTRUCTURING
Laurent Lemaire Executive Vice President, Finance, Procurement and IT
Laurent Guillot Chief Executive Officer

ANNUAL RESULTS 2022 2
3 NEXT STEPS AND OUTLOOK
Laurent Guillot Chief Executive Officer




(1) Calculated without taking into account the directors representing the employees
(2) Afep-Medef code, without taking into account the employee representatives

4
First steps to end dysfunctional practices quickly
A Refoundation Plan to restore the trust of our stakeholders
Since November 2022
A major financial restructuring to ensure the company's sustainability and to finance the Refoundation




Major progress on labor relations, recruitment and training

Implementation of the medico-healthcare project (supervision, Medical Commission, catering, etc.) and mediation mechanisms in Europe


The first steps towards the "mission-driven company", focused on care, in line with contemporary sustainability issues
SOCIETY
A complete overhaul of the financial structure is well underway and its implementation, in accordance with the timetable defined on November 15, will allow the financing of the Refoundation plan



6
ANNUAL RESULTS 2022



7

8
ANNUAL RESULTS 2022


9


Our PEOPLE

Our PATIENTS, our RESIDENTS and their FAMILIES

SOCIETY
STAKEHOLDERS
14/02 Lock-up Agreement Groupement - SteerCo - ORPEA 10/03 Signing of Lock-up Agreement by c. 51% of unsecured financial creditors 20/03 Agreement with G6 banks: new money debt and misc. amendments 24/03 Judgment opening of the accelerated safeguard procedure
Only plan capable of ensuring the long-term financing of the company Conversion of the debt is essential, mechanically leading to a massive dilution of existing shareholders
Backed by long-term institutional investors: Caisse des Dépôts et Consignation, CNP, MAIF, MACSF
Support from main banking partners (G6) and a majority (c. 51%) of Orpea SA unsecured creditors
Target of 20% to 25% of owned real estate in Orpea's portfolio



Laurent Lemaire
Group CFO, Procurement, Information Systems


Impacted by the inflationary environment and impairment of assets


Taking into account :
the Company considers, at the date of closing of the accounts, that it has cash resources compatible with its projected commitments and is thus in a position to meet its cash requirements over the next 12 months.
On this basis, the Board of Directors has approved the financial statements for the year ending December 31, 2022 as a going concern.
Audit procedures on consolidated financial statements have been performed by the Group Auditors. The audit report will be issued after verification of the management report and finalisation of the procedures required for the filing of the Universal Registration Document. It will include an observation highlighting the justification, by management, in the financial statements of the going concern principle, as well as one highlighting the change in methodology regarding IAS 16 with the end of the revaluation model pertaining to operating properties, land and buildings owned and operated by the Group.
| Evolution of revenue by geographic area | |||||
|---|---|---|---|---|---|
| €m | R evenue 2021 |
R evenue 2022 |
Growth % | Organic Growth % * |
|
| F R ANCE B E NE LUX UK IR E LAND |
2,643 | 2,802 | +6.0% | +4.3% | |
| CE NTR AL E UR OP E |
1 ,086 |
1 ,1 97 |
+1 0.2% |
+5.5% | |
| E AS TE R N E UR OP E |
395 | 435 | +1 0.2% |
+8.6% | |
| IB E R IAN P E NINS ULA + LATAM |
1 71 |
242 | +41 .3% |
+1 6.8% |
|
| OTHE R COUNTR IE S |
3 | 4 | +32.6% | +20.9% | |
| T OT AL |
4,299 | 4,681 | +8.9% | +5.5% |
*Organic growth of Group revenue reflects the following factors: 1. The year-on-year change in the revenue of existing facilities as a result of changes in their occupancy rates and daily price; 2. The year-on-year change in the revenue of refurbished facilities or those where capacity has been increased in the current or year-earlier period; 3. Revenue generated in the current period by facilities opened during the year or year-earlier period, and the change in revenue of recently acquired facilities by comparison with the previous equivalent period.
Overall occupancy rate increases thanks to the following elements:
Group occupancy rate (nursing homes and clinics) increases over the year: +60bps
Decline in the occupancy rate of nursing homes in France due to the crisis faced by Orpea: -400bps
(84.6% at 12.31.2022 vs 88.5% at the end of January 2022)
| Average occupancy rate | 2021 | 2022 | Var. |
|---|---|---|---|
| F rance B enelux UK Ireland |
83.8 % |
83.6 % |
(20) bp |
| Central E urope |
78.1 % |
79.1 % |
+1 00 bp |
| E astern E urope |
79.9 % |
81 .9 % |
+200 bp |
| Iberian P eninsula and Latam |
76.4 % |
78.0 % |
+1 60 bp |
| Other countries | n s |
n s |
n.a. |
| T otal Group |
81 .0 % |
81 .6 % |
+60 bp |


| (*) nd of period data E |
. of sites No 2021 |
. of beds No 2021 |
. of sites No 2022 |
. of beds No 2022 |
|---|---|---|---|---|
| F R ANCE BE NE LUX UK IR E LAND |
530 | 43 076 , |
551 | 44 1 70 , |
| CE NTR AL E UR OP E |
234 | 23 597 , |
237 | 23 765 , |
| AS OP E TE R N E UR E |
116 | 671 1 1 , |
24 1 |
2 764 1 , |
| NINS IBE R IAN P E ULA LATAM + |
6 8 |
8 934 , |
9 7 |
0 007 1 , |
| OTHE COUNTR S R IE |
1 | 1 54 |
1 | 1 54 |
| T OT AL |
949 | 87 432 , |
992 | 90 860 , |
| +4 5% |
+3 9% |
(*) Number of facilities, beds and flats in operation, at the end of the period for the fully consolidated entities, excluding ambulatory locations.


| €m | His torical 2021 * |
Actual 2022 |
Var. Var. |
|
|---|---|---|---|---|
| R evenue |
4,299 | 4,681 | +8.9% | |
| S taff costs |
(2,644) | (3,028) | +1 4.5% |
|
| % of As a revenue |
(61 5)% |
(64 7)% |
-31 8 pb |
|
| Other expenses | (584) | (873) | +49.5% | |
| As % of a revenue |
(1 6)% 3 |
(1 7)% 8 |
-506 pb | |
| E B IT DAR |
1 ,070 |
780 | -27.1 % |
|
| E BIT DAR % |
24.9 % |
1 6.7 % |
-824 bp |



| €m | 2021 E BIT DAR |
2022 E BIT DAR |
Var % 2021 vs |
2021 E BIT DAR % |
2022 E BIT DAR % |
Var |
|---|---|---|---|---|---|---|
| F B enelux UK Ireland rance |
694 | 445 | (35 9)% |
26 3 % |
1 5 9 % |
(1 039) bp |
| Central E urope |
284 | 245 | (13 7)% |
26 1 % |
20 5 % |
(568) bp |
| E E astern urope |
6 1 |
6 3 |
+3 0% |
1 5 4 % |
1 4 4 % |
(1 00) bp |
| Iberian eninsula and P Latam |
3 2 |
2 4 |
(23 4)% |
1 8 7 % |
1 0 1 % |
(856) bp |
| Other countries |
(1 ) |
2 | n s |
n s |
n s |
n s |
| T OT AL |
1 070 , |
780 | (27 )% 1 |
24 9 % |
1 6 7 % |
(824) bp |
His torical Actual Var. (%) His torical Actual Var.
• Mainly inflation effect (tempered in Germany by hedgingon energy costs)


Evolution of the value of operating properties held
Financial partnerships
Non-current items





(Goodwill and licences impairment tests)
| Total (excluding taxes): |
€(3.1)bn |
|---|---|
| • Fixed assets: |
€(1.0)bn |
| • Licences: |
€(1.4)bn |
| • Goodwill: |
€(0.4)bn |
| • Other assets: |
€(0.2)bn |


Impairment tests of intangible assets (IAS 36)
Evolution of the value of operating properties held
Financial partnerships
Non-current items

Reduction corresponding to the cumulative net amount of IAS revaluations recorded in the accounts at 12/31/2021 net of reversals on deferred taxes liabilities
(€1.9bn – €0.4bn)

ANNUAL RESULTS 2022

Forecast by facility as part of the Strategic plan presented on November 15, 2022
1
2
5.1% in 2022vs ~4.8% in 2021 (the 2021 average yield has been recalculated according to the method used for FY2022)




Impairment tests of intangible assets (IAS 36)
Evolution of the value of operating properties held
Non-current items








Impairment tests of intangible assets (IAS 36)
Evolution of the value of operating properties held
Financial partnerships
Non-current items

| items Non 2022 -current |
||
|---|---|---|
| IAS 36 Depreciations |
081 3 , |
|
| (assets construction/other) Other real depreciations under estate |
372 | |
| of financial receivables Depreciation |
534 | |
| Crisis refinancing management expenses - |
50 | |
| Crisis HR management expenses - |
26 | |
| Crisis others management expenses - |
||
| (including adjustments) Others receivable accounts |
24 1 |
|
| TOTAL | 4 223 , |
NB : gross amounts before tax.


Impairment tests of intangible assets (IAS 36)
Evolution of the value of operating properties held
Financial partnerships
Non-current items




| €m | 2021 | 2022 | ||
|---|---|---|---|---|
| E B ITDAR |
1 070 , |
780 | ||
| % E BITDAR |
24 9 % |
6 % 1 7 |
Depreciations on new assets + additional IFRS 16 | |
| E B ITDA |
1 041 , |
756 | charge (new facilities) | |
| % E BITDA |
24 2 % |
6 2 % 1 |
||
| D&A and provisions |
(645) | (805) | Impact of the increase of spreads in June Refinancing | |
| E B IT |
396 | (49) | + rise in interest rates | |
| inancial result F |
(249) | (31 9) |
||
| Non current |
(41 ) |
(4 223) , |
Mainly IAS 36 impact + impairments of real estate and | |
| before Net income tax |
1 06 |
(4 ) 591 , |
receivables with financial partners | |
| Income tax |
(38) | 596 | ||
| profit/(loss) S hare in of associates and J Vs |
(1 ) |
(33) | Positive impact of the reversal of IAS 36 deferred tax | |
| Minority interests |
(2) | 1 | liabilities | |
| (Group share) result Net |
65 | (4 027) , |
His torical Actual
Note: EBITDA hors IFRS 16 2021 : 682 M€ / 15.9% margin ; 2022 : 342 M€ / 7.3% margin
Depreciations on new assets + additional IFRS 16
Impact of the increase of spreads in June Refinancing
Mainly IAS 36 impact + impairments of real estate and
Positive impact of the reversal of IAS 36 deferred tax

| (M€) | ||
|---|---|---|
| excl S 6 E B IT DA IF R 1 |
342 | |
| / adjustments cash cash E BITDA non |
1 1 |
|
| (excl tax)* Change in WCR income |
(23) | |
| Operating CAP E X |
(1 36) |
|
| (cash) Income taxes |
(72) | |
| Operational Cash F low |
1 22 |
2022 |
| Development capex |
(638) | |
| eal disposals R E state |
1 32 |
|
| Non-current items |
(1 52) |
|
| Net financial expenses |
(21 5) |
|
| Net financial investments |
(94) | |
| Changes in perimeter |
(31 ) |
|
| Others | (40) | |
| (excl ) VAR NE T F INANCIAL DE B T IF R S |
(91 6) |
|
| (excl ) financial 2/31 /2021 Net debt IF R S 1 |
(7 944) , |
|
| Change in debt net |
(91 6) |
|
| (excl ) 2/31 /2022 financial debt S Net IF R 1 |
(8 860) , |
(*) excluding taxes, partnership financing and security deposits vs. €59m presented on November 15, 2022
Reduction vs. the BP presented on November 15,
Mainly in The Netherlands
Mainly Orpea crisis-related costs
Related to past commitments

| €m | OR P E A S A |
S ubsidiaries |
Total | |
|---|---|---|---|---|
| J une 2022 F inancing |
3,227 | - | 3,227 | 1 |
| G6 New Money | - | - | - | |
| S ecured debt |
320 | 1 ,762 |
2,082 | |
| P rivate P lacements € |
32 | - | 32 | |
| S ub-total secured debt |
3,579 | 1 ,762 |
5,341 | |
| Listed bonds | 1 ,400 |
- | 1 ,400 |
|
| Bank debt | 1 55 |
41 6 |
571 | |
| P rivate P lacements € |
698 | - | 698 | |
| S chuldschein/NS V |
1 ,570 |
1 36 |
1 ,706 |
|
| S ub-total unsecured debt |
3,823 | 552 2 |
4,375 | |
| Gross financial debt (excl. IF R S ) |
7,402 | 2,31 4 |
9,71 6 |
|
| Cash flow | 856 | Net debt at end 2021 | ||
| Net financial debt as at 31 .1 2.2022 (excl. IF R S ) |
8,860 | 7,944 | ||
| S adjustments IF R |
02 1 - |
|||
| Net financial debt (IF R S view, excl. IF R S 1 6) |
8,758 | 7,91 0 |
(*) under a conciliation procedure approved on June 10, 2022. Terms and Conditions subject to adjustment pursuant to the agreement concluded on March 17, 2023 with the main banking partners
2
Var.
91 6
848
o Settlement of the entire amount (€3.8 billion) under the accelerated safeguard procedure opened on 24 March 2023, through a capital increase with maintenance of the preferential subscription rights of the existing shareholders (**) guaranteed by all unsecured creditors who will subscribe, if necessary, by way of compensation with their existing claims (conversion of the debt into shares)
(**) any cash proceeds resulting from the subscription by the existing shareholders to this capital increase being used in full to reimburse the Company's unsecured financial creditors at par value in due proportion



0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
2.00




| Restated from the withdrawal of IAS 16 |
||||
|---|---|---|---|---|
| (in euros) million |
/1 2/2022 31 |
/1 2/2021 31 R estated * |
/1 2/2021 31 P ublished |
Impairment of intangible |
| AS S TS E |
assets | |||
| Goodwill | 1 362 491 , , |
1 668 553 , , |
1 668 553 , , |
|
| Intangible assets, net |
1 592 231 , , |
3 076 406 , , |
3 076 406 , , |
|
| P plant and equipment roperty, , net |
4 374 692 , , |
5 324 490 , , |
7 237 005 , , |
Real estate |
| Assets in progress |
626 633 , |
832 385 , |
832 385 , |
(including IAS |
| R ight-of-use assets |
3 499 987 , , |
3 072 567 , , |
3 072 567 , , |
16 withdrawal) |
| and Investments in associates joint ventures |
852 7 , |
84 58 1 , |
84 58 1 , |
|
| Non-current financial assets |
1 80 997 , |
94 703 , |
94 703 , |
|
| Deferred tax assets |
581 556 , |
0 1 1 5 51 , |
0 1 1 5 51 , |
|
| Non-current as s ets |
1 2 226 438 , , |
1 4 268 772 , , |
1 6 1 81 287 , , |
|
| Inventories | 6 00 1 1 , |
1 5 735 , |
1 5 735 , |
|
| T rade receivables |
455 368 , |
431 630 , |
431 630 , |
|
| Other receivables , accruals and prepayments |
586 957 , |
01 1 5 354 , , |
01 1 5 354 , , |
|
| Cash and cash equivalents |
856 41 7 , |
952 369 , |
952 369 , |
Financial |
| Current as s ets |
91 842 1 4 , , |
2 088 41 5 , , |
2 088 41 5 , , |
Partnerships |
| Assets held for sale |
353 1 54 , |
387 952 , |
387 952 , |
|
| TOTAL AS S TS E |
494 1 4 435 , , |
071 81 2 1 7 , , |
8 984 327 1 , , |
| Restated from the withdrawal of IAS 16 | |||||
|---|---|---|---|---|---|
| (in euros) million |
/1 2/2022 31 |
/1 2/2021 31 estated R * |
/1 2/2021 31 ublished P |
Negative shareholders' |
|
| E QUITY AND L IAB IL ITIE S |
equity | ||||
| Total cons olidated equity |
(1 235) 502 , , |
2 364 335 , , |
81 228 3 1 , , |
||
| Long-term financial debt |
1 378 335 , , |
7 006 775 , , |
7 006 775 , , |
||
| Non-current lease commitments |
3 424 1 52 , , |
2 968 098 , , |
2 968 098 , , |
||
| rovisions P |
296 95 1 , |
48 436 1 , |
48 436 1 , |
||
| P rovisions for pensions and other employee benefit obligations |
66 1 95 , |
75 035 , |
75 035 , |
Reversal of deferred tax | |
| Deferred liabilities and other liabilities tax non-current |
81 3 993 , |
997 009 , |
1 433 660 , , |
liabilities (IAS 36) | |
| Non-current liabilities |
5 978 870 , , |
1 1 1 95 353 , , |
1 1 632 004 , , |
||
| hort-term financial debt S |
8 236 459 , , |
1 855 524 , , |
1 855 524 , , |
Including €6.5bn reclassified | |
| Current lease commitments |
344 31 7 , |
297 098 , |
297 098 , |
from long-term to short-term | |
| P rovisions |
(0) | 22 464 , |
22 464 , |
due to the direct and indirect default related to the breach of R1/R2 covenants |
|
| rade payables T |
326 954 , |
797 334 , |
797 334 , |
||
| T ax and payroll liabilities |
41 1 874 , |
329 1 07 , |
329 1 07 , |
||
| Current income liabilities tax |
2 1 1 471 , |
68 808 , |
68 808 , |
||
| Other payables , accruals and prepayments |
529 494 , |
633 297 , |
633 297 , |
||
| Current liabilities |
9 961 569 , , |
3 541 095 , , |
3 541 095 , , |
||
| L iabilities held for sale |
56 232 , |
0 | 0 | ||
| TOTAL E QUITY AND LIAB ILITIE S |
1 4 494 435 , , |
1 7 071 81 2 , , |
1 8 984 327 , , |
| Nov 15th 2022 |
Actual 2022 | |
|---|---|---|
| Revenue | €4,688m | €4,681m |
| EBITDAR | €797m | €780m |
| Net financial debt (excluding IFRS 16) | €9.02bn | €8.86bn |
| Development Capex (1) | €705m | €638m |
[1] : mainly construction of new facilities


In accordance with applicable legal provisions, the Company has requested and obtained from the President of the Nanterre Commercial Court an extension of the deadline for the Shareholders' Meeting convened to approve the financial statements for the year ending December 31, 2022. The order issued by the President of the Nanterre Commercial Court on May 11, 2023 extends the meeting deadline to December 29, 2023. Consequently, the Company will convene and hold its annual shareholders' meeting before this date and, in any event, once the new shareholders have acquired their stake in the Company's capital.

Key parameters


| The June 2022 plan was based on major real estate disposals |
• 2022-25: €2bn disposal commitment • From April 2022: discussions initiated with real estate investors (mid-sized operations and larger asset portfolios) |
|---|---|
| Several unfavourable developments have jeopardised the implementation of the disposals in the anticipated proportions and timing |
• Rising interest rates impacting the real estate market • Weakened operating performance in H1 2022 (inflation, occupancy rates) • Continued strategic review and anticipation of first asset write-downs Deteriorated perception, uncertainty on covenants, and expectation of excessive leverage at end 2022 (>25x) |
| The success of the Refoundation Plan requires a major financial restructuring as envisaged under the accelerated safeguard procedure |
› Reduction of net debt by converting unsecured debt into capital and providing new capital funding › Securing the resources needed for the Refoundation plan: provision of new money and adjustment of the terms and conditions of the June 2022 loan |



(1) Excluding a possible reduction of the nominal value and/or consolidation of shares prior to the implementation of the capital increases
Not approved by at least one of the classes of affected parties
| 1 Conversion of unsecured debt into capital |
2 Capital increase Groupement New Money |
3 Capital increase with preferential subscription rights |
|
|---|---|---|---|
| Main parameters and terms |
Amount c. €3.8bn • Capital increase with preferential subscription rights for existing shareholders, guaranteed by all unsecured financial creditors of ORPEA SA, SA who subscribe, if applicable, by way of set-off against their existing receivables • Any cash proceeds resulting from the subscription by the existing shareholders will be used in full to repay the unsecured financial creditors of ORPEA SA at par value in due proportion • Approximately 65bn new shares issued |
Amount c. €1.15bn • Capital increase reserved for the Groupement, in cash, with priority right of shareholders if the shareholders, as a class of affected parties, do not approve the accelerated safeguard plan • This priority right will exclusively benefit the shareholders existing before the launch of the first capital increase, and will therefore not benefit the unsecured creditors who may become shareholders of the Company at the end of step 1 • Subscription of the Groupement up to the difference between the total amount of the capital increase and any amount subscribed by the shareholders via their priority right • Approximately 65bn new shares issued |
Amount c. €0.4bn • Capital increase in cash with preferential subscription rights for existing shareholders: • Subscribed on an irreducible basis by the members of the Groupement for approximately €0.2bn by exercising their preferential subscription rights • Open to all shareholders (including creditors who have become shareholders) and backstopeped by the "SteerCo" • Approximately 29bn new shares issued |
| Capital structure after each transaction (assuming no participation of existing shareholders) |
• Unsecured creditors converted to equity: 99.9% • Existing shareholders: 0.1% |
• Groupement: 50.2% • Unsecured creditors converted to equity: 49.8% • Existing shareholders: 0.05% |
• Groupement: 50.2% • Unsecured creditors converted to equity: 40% • Unsecured creditors providing new equity (SteerCo): 9.8% • Existing shareholders: 0.04% |
| Theoretical issue prices (1) |
> 3,3x • Approximately €0.059 per share |
• Approximately €0.018 per share Transactions resulting in massive dilution for existing shareholders (and 10 times higher than the dilution incurred in the event of approval of the plan by each of the classes of affected parties ) and based on issue prices that are significantly lower than the current |
• Approximately €0.013 per share share price |
(1) Excluding a possible reduction of the nominal value and/or consolidation of shares prior to the implementation of the capital increases
The financial restructuring is also based on the implementation of a RCF by the main banking partners and on the modification of the terms and conditions of the June 2022 loan

| NEW MONEY (RCF) TOTAL: €400m + €200m |
MAIN T&C, | • Margin: 2.00% p.a. |
|---|---|---|
| D1: €400m (échéance 30/06/2026) D1A - €200m to be drawn by end of May 2023 |
COMMITMENTS AND GUARANTEES GRANTED UNDER NEW MONEY FINANCING |
• Pledge on the shares issued by ORESC 26 directly holding 100% of the capital and voting rights of Niort 94 and Niort 95 • Commitment to maintain an LTV ratio of less than 55% at 31/12/2023 and less than 50% thereafter |
| D1B - €200m to be drawn in July 2023 |
||
| D2+D3 = 2 x €100m "Bridge to Equity" available in the event of an appeal against the waiver of the launch of a takeover bid to be granted by the AMF (which would result in a delay of the planned capital increases) Drawings D1B, D2 and D3 remain respectively subject to the establishment of securities and the approval of the safeguard plan by the Commercial Court of Nanterre |
MAIN T&C AND COMMITMENTS RESULTING FROM THE AMENDMENT OF THE TERMS AND CONDITIONS OF THE JUNE 2022 CREDIT |
• Margin: 2.00% p.a. • Final maturity: 31/12/2027 • Contractual amortisation: €200m per year over 2023, 2024 and 2026; €300m in 2025 • Property disposals > €1.25bn by end 2025 - replacing previous commitment of €2bn • Annual cash sweep applicable from 30/06/2025: allocation of 75% of net disposal proceeds of property and operating assets (less contractual amortization) subject to maintaining a minimum liquidity of €300m until the end of the year concerned • Minimum liquidity covenant (> €300m tested on a half-yearly basis) |




Notes:






| 2022 Real | 2025 actualized1 | CAGR 22-25 |
|
|---|---|---|---|
| Revenue | €4,681m | €6,102m Unchanged |
+9% |
| EBITDAR (% CA) |
€780m (16.7%) |
€1,216m (19.9%) €30m reclassification IT Capex Opex to |
+16% |
| EBITDA excl. IFRS 162 (% CA) |
€342m | €671m ~€45m rental income from property disposals |
+25% |
| # BEDS | 90,860 | 96,806 Unchanged |
+2% |
Note : (1) 2025 figures from 2022 geographical scope, (2) IFRS 16 EBITDA - external property rental expenses not considered in IFRS 16 EBITDA (net of all external property rentals)
53 ANNUAL RESULTS 2022

| €m [reminder of figures presented on 11/15/2022] |
2022R | 2023 | 2024 | 2025 | 2022-2025 |
|---|---|---|---|---|---|
| Operating Cash-Flow1 | 122 [159] |
43 [132] |
322 [295] |
416 [471] |
903 €(53)m novembre 22 vs. |
| Development Capex | (638) [(705)] |
(478) [(544)] |
(282) [(216)] |
(124) [(132)] |
(1,522) +€75m novembre 22 vs |
| Net balance | (516) [(646)] |
(435) [(412)] |
40 [79] |
292 [339] |
(619) +€22m novembre 22 vs |
Note : (1) EBITDA excluding IFRS 16 - change in WCR and other non-cash current items - Maintenance and IT CAPEX - Taxes paid

,0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000



,0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000







| €m | R evenue Q1 2022 |
R evenue Q1 2023 |
Growth | Organic Growth* |
|---|---|---|---|---|
| enelux Irlande F B UK rance |
679 | 720 | +6 0% |
8% +5 |
| Central E urope |
283 | 322 | +1 3 7% |
+1 2 6% |
| E E astern urope |
1 01 |
1 21 |
+1 9 7% |
+1 9 6% |
| Iberian peninsula and Latam |
5 5 |
6 9 |
+24 7% |
+21 8% |
| Other countries |
1 | 2 | +88 0% |
+3 4% |
| T OT AL |
1 1 20 , |
1 234 , |
+1 0 2% |
+9 5% |
| Occupancy (avg ) rate |
Q1 2022 |
Q1 2023 |
(bps) Var |
|---|---|---|---|
| France Benelux UK Ireland |
84 9% |
83 8% |
(115) bps |
| Central Europe |
78 1% |
81 5% |
bps 340 |
| Eastern Europe |
80 9% |
83 7% |
bps 287 |
| Iberian peninsula and Latam |
74 4% |
83 2% |
886 bps |
| Other countries |
83 5% |
42 9% |
(4062) bps |
| Total | 81 4% |
83 0% |
160 bps |
*Organic growth in Group revenues includes: 1. Change in revenue (N vs. N-1) of existing facilities resulting from changes in their occupancy rates and per diem rates; 2. Change in revenue (N vs. N-1) of facilities that have been restructured or whose capacity has been increased in N or N-1; 3. Revenue generated in N by facilities created in N or in N-1, and the change in revenue of recently acquired facilities over a period equivalent in N to the consolidation period in N-1.

Laurent Guillot Group Chief Executive Officer



Supporting the cultural transformation of the group
at the heart of our activities
Committing the company to a mission-based model

Completing the return to basics Continue the structuring of our financial, IT, purchasing and HR functions affected by the crisis
Develop "trust & inspire" management based on responsibility, ethics and trust
Implement the group's medical and nursing project by decompartmentalising our professions and our establishments Strengthening care and support
Restoring financial stability Successfully implement the financial restructuring plan
By living our values, by affirming our "Raison d'être", by transforming our business model
A responsible group, sustainable practices, a positive impact
A corporate project with a mission focused on care, in line with contemporary sustainability issues

This document contains forward-looking statements that involve risks and uncertainties, including references, regarding the Group's expected growth and profitability in the future that may significantly impact the expected performance indicated in the forward-looking statements. These risks and uncertainties relate to factors out of the control of the Company and not accurately estimated, such as market conditions. Any forward-looking statements made in this document are statements about the Company's beliefs and expectations and should be evaluated as such. Actual events or results may differ from those described in this document due to a number of risks or uncertainties described within Chapter 3 of the Company's 2022 Universal Registration Document, which is available on the Company's website, on the French financial markets regulator, AMF's website (www.amf-france.org), and in the 2022 Half-Year Financial Report published on September 30, 2022.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.